ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

ATXI Avenue Therapeutics Inc

5.8356
-2.94 (-33.50%)
After Hours
Last Updated: 16:10:32
Delayed by 15 minutes

Period:

Draw Mode:

Volume 226,812
Bid Price 5.85
Ask Price 6.75
News -
Day High 8.99

Low
0.0852

52 Week Range

High
8.99

Day Low 5.78
Company Name Stock Ticker Symbol Market Type
Avenue Therapeutics Inc ATXI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-2.94 -33.50% 5.8356 16:10:32
Open Price Low Price High Price Close Price Prev Close
7.58 5.78 8.99 6.11 8.775
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
25,773 226,812 $ 7.60 $ 1,722,887 - 0.0852 - 8.99
Last Trade Time Type Quantity Stock Price Currency
16:10:18 1 $ 6.02 USD

Avenue Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
94.46M 13.25M - 0 -10.38M -0.78 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Avenue Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ATXI Message Board. Create One! See More Posts on ATXI Message Board See More Message Board Posts

Historical ATXI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.13468.990.08520.10684084,973,6925.704,235.51%
1 Month0.1548.990.08520.11685781,860,3735.683,689.35%
3 Months0.1478.990.08520.14148991,834,7235.693,869.80%
6 Months0.388.990.08520.23130833,986,5105.461,435.68%
1 Year0.898.990.08520.24486072,015,8554.95555.69%
3 Years72.0083.550.08525.331,816,633-66.16-91.90%
5 Years71.40188.400.08529.781,145,208-65.56-91.83%

Avenue Therapeutics Description

Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.

Your Recent History

Delayed Upgrade Clock